Quotient Limited Provides First Quarter Fiscal 2023 Results

MosaiQ™ Solution Commercial Execution: Extended IH Launch: $1.4 million MosaiQ bookings completed with $0.4 million in revenue in the first...

Related Keywords

Jersey ,Netherlands ,Singapore ,Florida ,United States ,Boston ,Massachusetts ,Delft ,Zuid Holland ,Orlando ,Eysins ,Switzerland General ,Switzerland ,Spain ,Castillay Le ,Hemoterapiay Hemodonaci ,Steven Zuiderwijk ,Distribution Network ,Extractable Nuclear Antibody ,University Of Delft ,Strategic Business Development ,Nuclear Antibody ,Strategy Business Development ,Quotient Limited ,Philips ,Master Of Business Administration ,Leadership Team ,Scientific Medical Affairs ,Extractable Nuclear Antibodies ,Boston Consulting Group ,Extended Immunohematology ,Extended Serological Disease Screening ,Connective Tissue Autoimmune Disease ,Medical Affairs ,Transfusion Interregionale ,Centro De Hemoterapia ,Advisory Board ,Scientific Advisory Board ,Autoimmune Testing ,Mosaiq Immunohematology Donor Extended Microarray ,Chief Strategy ,Business Development Officer ,Channel Islands ,Chief Executive Officer ,Infynity Biomarkers ,Mosaiq Serology Disease Screening ,Connective Tissue Diseases ,Anti Nuclear Antibody ,Mosaiq Innovator ,Chief Strategic Business Development Officer ,Precision Diagnosis ,Middle East ,Mechanical Engineering ,Business Administration ,First Quarter Financial Results ,Nasdaq Qtnt ,